New hope for ulcerative colitis sufferers: experimental drug enters Mid-Stage trial
NCT ID NCT07335055
First seen Jan 12, 2026 · Last updated May 25, 2026 · Updated 22 times
Summary
This study tests a new drug called HSK47388 in 150 adults with moderate-to-severe ulcerative colitis, a chronic bowel disease. Participants will receive either the drug or a placebo to see if it reduces symptoms like diarrhea and bleeding. The goal is to find a safer, more effective treatment option for those who haven't responded to standard therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sir Run Run Shaw Hospital
RECRUITINGHangzhou, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.